You just read:

Novartis Reports Omalizumab Significantly Improved Chronic Idiopathic Urticaria Symptoms in Patients Who Failed Standard Therapy

News provided by

Novartis Pharmaceuticals Corporation

Feb 24, 2013, 01:17 EST